News from viewray, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 12, 2023, 06:30 ET ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting

ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of ...

May 10, 2023, 16:01 ET ViewRay Announces First Quarter 2023 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023...

May 09, 2023, 16:10 ET ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023

iewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of first quarter 2023 financial results. ViewRay will hold a conference...

Apr 13, 2023, 06:00 ET ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today provided a business update and announced preliminary financial results for the quarter ended March ...

Apr 12, 2023, 17:25 ET ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023

ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss results on Thursday, April 13, 2023, at 8:00 AM ET. The dial-in number for...

Mar 07, 2023, 06:30 ET Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients

ViewRay, Inc. (NASDAQ: VRAY) today announced the Czech Ministry of Health has approved the purchase of ViewRay's MRIdian system to bring advanced...

Feb 27, 2023, 16:05 ET ViewRay Announces Fourth Quarter and Full Year 2022 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the fourth quarter and full fiscal year ended December 31, 2022....

Jan 31, 2023, 06:30 ET ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023

ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of fourth quarter 2022 financial results. ViewRay will hold a conference ...

Jan 20, 2023, 17:05 ET ViewRay Enters into Cooperation Agreement with Hudson Executive Capital

ViewRay, Inc. (NASDAQ: VRAY) today announced that it has reached an agreement with Hudson Executive Capital LP ("HEC") to appoint Sai Nanduri, Senior ...

Jan 12, 2023, 11:53 ET Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

ViewRay, Inc. (NASDAQ: VRAY) today announced that findings from the phase III randomized controlled MIRAGE trial (NCT04384770) were published on...

Jan 09, 2023, 06:00 ET ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced preliminary financial results for the fourth quarter and full fiscal year ended December ...

Jan 05, 2023, 09:41 ET Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment

ViewRay, Inc. (NASDAQ: VRAY) announced today that Chindex Medical Limited (Chindex), through its subsidiary, has ordered 10 MRIdian® MR-Guided...

Jan 05, 2023, 06:00 ET University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems

ViewRay, Inc. (NASDAQ: VRAY) today announced that the University Hospitals (UH) Seidman Cancer Center in Cleveland has selected a MRIdian MR-Guided...

Nov 14, 2022, 17:15 ET ViewRay Expands Access to Non-Dilutive Capital With New Debt Facility

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced that it has entered into a new five-year loan facility agreement with MidCap Financial...

Nov 14, 2022, 06:30 ET ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the 34th Annual Piper Sandler Healthcare Conference. Scott Drake,...

Nov 10, 2022, 06:30 ET ViewRay® to Present at the Stifel 2022 Healthcare Conference

ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Stifel 2022 Healthcare Conference. Scott Drake, President and Chief ...

Nov 01, 2022, 17:18 ET ViewRay Announces Third Quarter 2022 Results

ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the third quarter ended September 30, 2022. Third Quarter 2022...

Oct 27, 2022, 06:30 ET MIRAGE Phase III Randomized Controlled Trial Demonstrates Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

ViewRay, Inc. (NASDAQ: VRAY) announced today that the final primary endpoint results from the phase III randomized single-center MIRAGE trial were...

Oct 24, 2022, 06:30 ET ViewRay Announces Primary Endpoint Outcome from First Prospective, Multi-Institutional Study to Deliver Ablative Doses of Radiation to Pancreatic Cancer Patients

ViewRay, Inc. (NASDAQ: VRAY) announced today that the findings from the first Phase II prospective international multi-institutional study to deliver ...

Oct 19, 2022, 06:30 ET MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian® MRI-Guided Radiation Therapy System will be featured at the 64th Annual...

Oct 18, 2022, 06:30 ET ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

ViewRay, Inc. (NASDAQ: VRAY) today announced the launch of a phase III randomized controlled trial titled "Locally Advanced Pancreatic cancer treated ...

Oct 14, 2022, 06:30 ET ViewRay Announces Conference Call for Third Quarter 2022 Financial Results to be Held After Market on November 1, 2022

ViewRay, Inc. (NASDAQ: VRAY) announced today details relating to the release of third quarter 2022 financial results. ViewRay will hold a conference...

Oct 06, 2022, 06:30 ET SUNY Upstate Cancer Center Chooses ViewRay's MRI-Guided Radiation Therapy System to Treat Cancer Patients

ViewRay, Inc. (NASDAQ: VRAY) today announced that SUNY Upstate Cancer Center in Syracuse, New York has selected MRIdian MRI-Guided Radiation Therapy...

Oct 06, 2022, 02:00 ET L'ospedale San Pietro Fatebenefratelli tratta il suo millesimo paziente con radioterapia guidata da MRI MRIdian®

ViewRay, Inc. (NASDAQ: VRAY) ha annunciato oggi che l'ospedale San Pietro Fatebenefratelli di Roma ha trattato il suo millesimo paziente con...

Oct 04, 2022, 06:30 ET San Pietro Fatebenefratelli Hospital Treats its 1,000th Patient with MRIdian® MRI-Guided Radiation Therapy

ViewRay, Inc. (NASDAQ: VRAY) today announced that San Pietro Fatebenefratelli Hospital in Rome has treated its 1,000th patient with MRIdian®...